BTL Aesthetics

Next-Generation BTL Vanquish ME for Fat Reduction

A study published in the Journal of Drugs in Dermatology (December 2016) found that the BTL Vanquish ME (Maximum Energy) from BTL Aesthetics was effectively redesigned for more efficient and homogenous energy delivery to targeted tissue, reducing 53% more fat versus the BTL Vanquish. The BTL Vanquish ME, which debuted in 2015, is FDA-cleared for the circumferential reduction of the abdomen and thighs.

BTL Vanquish Cleared for Nonsurgical Abdomen Reduction

BTL Vanquish Cleared for Nonsurgical Abdomen Reduction

The U.S. Food and Drug Administration (FDA) approved the BTL Vanquish (BTL Industries) device for circumferential reduction of the abdomen area. The platform features a panel array that emits selective RF energy with the largest spot size in the industry to treat the entire core in one application (without touching patients’ skin). It creates a high-frequency energy field that targets the thermal effects into the fat layer while protecting surrounding skin tissue.

Exilis ELITE FDA-Approved for Cellulite Reduction

Exilis ELITE FDA-Approved for Cellulite Reduction

The Exilis ELITE, a radiofrequency (RF)-based, skin-tightening platform, has been granted FDA approval for temporary reduction in the appearance of cellulite.

The monopolar focused RF device, which is engineered with advanced cooling, heats the dermis, causing collagen support tissues to remodel, tighten and firm. Using a new protocol to treat areas with underlying fat deposits, the device has also shown temporary improvements in the appearance of cellulite.